Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald E Low

Showing results (191-200 of 261) with videos related to

Pageof 27
Sort By:
JAMA|January 10, 2013
Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, CanadaVanessa G Allen, Leo Mitterni, Christine Seah, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 studyGeorge G Zhanel, Heather J Adam, Donald E Low, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaDonald E Low, Thomas M File, Paul B Eckburg, et al.
The New England Journal of Medicine|March 3, 2006
Outpatient gatifloxacin therapy and dysglycemia in older adultsLaura Y Park-Wyllie, David N Juurlink, Alexander Kopp, et al.
Infection and Immunity|September 14, 2002
Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae diseaseJeffrey D Fuller, Alvin C Camus, Carla L Duncan, et al.
Gastrointestinal Endoscopy|July 23, 2003
Use of self-expandable metallic stents in benign GI diseasesRaju P Wadhwa, Richard A Kozarek, Renee E France, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaThomas M File, Donald E Low, Paul B Eckburg, et al.
Journal of Bacteriology|October 14, 2011
Whole-genome sequence of Streptococcus pseudopneumoniae isolate IS7493Dea Shahinas, Gurdeep Singh Tamber, Gitanjali Arya, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2010
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, CanadaVanessa G Allen, David J Farrell, Anuradha Rebbapragada, et al.
Journal of Clinical Microbiology|May 8, 2004
Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococciPatrick Tang, Peter Ng, Ming Lum, et al.
Pageof 27

Showing results (191-200 of 261) with videos related to

Sort By:
Pageof 27
JAMA|January 10, 2013
Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, CanadaVanessa G Allen, Leo Mitterni, Christine Seah, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 2011
Antimicrobial susceptibility of 15,644 pathogens from Canadian hospitals: results of the CANWARD 2007-2009 studyGeorge G Zhanel, Heather J Adam, Donald E Low, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaDonald E Low, Thomas M File, Paul B Eckburg, et al.
The New England Journal of Medicine|March 3, 2006
Outpatient gatifloxacin therapy and dysglycemia in older adultsLaura Y Park-Wyllie, David N Juurlink, Alexander Kopp, et al.
Infection and Immunity|September 14, 2002
Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae diseaseJeffrey D Fuller, Alvin C Camus, Carla L Duncan, et al.
Gastrointestinal Endoscopy|July 23, 2003
Use of self-expandable metallic stents in benign GI diseasesRaju P Wadhwa, Richard A Kozarek, Renee E France, et al.
The Journal of Antimicrobial Chemotherapy|April 13, 2011
FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaThomas M File, Donald E Low, Paul B Eckburg, et al.
Journal of Bacteriology|October 14, 2011
Whole-genome sequence of Streptococcus pseudopneumoniae isolate IS7493Dea Shahinas, Gurdeep Singh Tamber, Gitanjali Arya, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2010
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, CanadaVanessa G Allen, David J Farrell, Anuradha Rebbapragada, et al.
Journal of Clinical Microbiology|May 8, 2004
Use of the Vitek-1 and Vitek-2 systems for detection of constitutive and inducible macrolide resistance in group B streptococciPatrick Tang, Peter Ng, Ming Lum, et al.
Pageof 27